{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T18:17:16Z","timestamp":1790705836806,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.pnpbp.2009.01.010","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T05:04:22Z","timestamp":1233032662000},"page":"475-481","source":"Crossref","is-referenced-by-count":55,"title":["Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia"],"prefix":"10.1016","volume":"33","author":[{"given":"A.F.Y.","family":"Al Hadithy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pechlivanoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Semke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Fedorenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kornetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ryadovaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.B.J.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Wilffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Bruggeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.M.","family":"Loonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2009.01.010_bib1","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ajmg.b.30746","article-title":"Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-Caribbean inpatients: differences in association with dopamine and serotonin receptors","volume":"147B","author":"Al Hadithy","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","article-title":"Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research","volume":"12","author":"Arranz","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.schres.2006.01.010","article-title":"Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis","volume":"83","author":"Bakker","year":"2006","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib43","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.mp.4000847","article-title":"Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia","volume":"6","author":"Basile","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1017\/S0033291700038496","article-title":"Sub-syndromes of tardive dyskinesia and some clinical correlates","volume":"22","author":"Brown","year":"1992","journal-title":"Psychol Med"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00002826-198309000-00003","article-title":"Neuroleptic-induced dyskinesias in children","volume":"6","author":"Campbell","year":"1983","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archpsyc.1976.01770070088010","article-title":"Comparative doses and costs of antipsychotic medication","volume":"33","author":"Davis","year":"1976","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1176\/appi.ajp.161.7.1159","article-title":"Methods for analysis of skewed data distributions in psychiatric clinical studies: working with many zero values","volume":"161","author":"Delucchi","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1134\/S0012496606060123","article-title":"The diversity of Y-chromosome lineages in indigenous population of South Siberia","volume":"411","author":"Derenko","year":"2006","journal-title":"Dokl Biol Sci"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib7","first-page":"314","article-title":"Ethnicity and movement disorders","volume":"63","author":"Eastham","year":"1996","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib8","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/106002809703101114","article-title":"Ethnicity and antipsychotic response","volume":"31","author":"Frackiewicz","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib9","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1001\/archpsyc.1977.01770220088010","article-title":"The assessment of tardive dyskinesia","volume":"34","author":"Gardos","year":"1977","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 4","key":"10.1016\/j.pnpbp.2009.01.010_bib10","first-page":"15","article-title":"Review of incidence studies of tardive dyskinesia associated with typical antipsychotics","volume":"61","author":"Glazer","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib47","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1097\/00004714-198808001-00003","article-title":"Predictors of occurrence, severity, and course of tardive dyskinesia in an outpatient population","volume":"8","author":"Glazer","year":"1988","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib46","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/ajp.141.1.20","article-title":"Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents","volume":"141","author":"Gualtieri","year":"1984","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib11","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/jnnp.51.12.1525","article-title":"Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60\u00a0years: relationship to demographic, clinical, treatment, and neuropsychological variables","volume":"51","author":"Gureje","year":"1988","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1017\/S0033291700011089","article-title":"The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors","volume":"19","author":"Gureje","year":"1989","journal-title":"Psychol Med"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1600-0447.1990.tb03069.x","article-title":"A statistical trial of subclassification for tardive dyskinesia","volume":"82","author":"Inada","year":"1990","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib14","doi-asserted-by":"crossref","first-page":"52S","DOI":"10.1097\/00004714-198808001-00010","article-title":"Tardive dyskinesia: prevalence, incidence, and risk factors","volume":"8","author":"Kane","year":"1988","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1353\/hub.2003.0006","article-title":"High levels of Y-chromosome differentiation among native Siberian populations and the genetic signature of a boreal hunter-gatherer way of life","volume":"74","author":"Karafet","year":"2002","journal-title":"Hum Biol"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib41","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S0033291700047401","article-title":"Sub-syndromes of tardive dyskinesia","volume":"10","author":"Kidger","year":"1980","journal-title":"Psychol Med"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib16","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1017\/S1461145705005389","article-title":"Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype","volume":"8","author":"Lerer","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/NMM:5:3:243","article-title":"Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients","volume":"5","author":"Liou","year":"2004","journal-title":"Neuromolecular Med"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/jcp.0b013e31814f1105","article-title":"Measuring movement disorders in antipsychotic drug trials: the need to define a new standard","volume":"27","author":"Loonen","year":"2007","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/archpsyc.1993.01820210057007","article-title":"Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study","volume":"50","author":"Morgenstern","year":"1993","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1034\/j.1600-0447.2001.00401.x","article-title":"Familial occurrence of tardive dyskinesia","volume":"104","author":"Muller","year":"2001","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.biopsych.2005.12.018","article-title":"Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression","volume":"61","author":"Myers","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/BF02246639","article-title":"Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study","volume":"123","author":"Paulsen","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00004850-198904000-00001","article-title":"Guidelines for the dosage of neuroleptics. I: chlorpromazine equivalents of orally administered neuroleptics","volume":"4","author":"Rey","year":"1989","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/026988110401800303","article-title":"Receptor mechanisms in the treatment of schizophrenia","volume":"18","author":"Reynolds","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0091-3057(94)90085-X","article-title":"Possible genetic factors underlying the pathophysiology of tardive dyskinesia","volume":"49","author":"Rosengarten","year":"1994","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00004850-198904000-00002","article-title":"Guidelines for the dosage of neuroleptics. II: changing from daily oral to long acting injectable neuroleptics","volume":"4","author":"Schulz","year":"1989","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/sj.mp.4000511","article-title":"Genotypic association between the dopamine D3 receptor and tardive dyskinesia in chronic schizophrenia","volume":"4","author":"Segman","year":"1999","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/sj.tpj.6500194","article-title":"Association of dopaminergic and serotonergic genes with tardive dyskinesia in patients with chronic schizophrenia","volume":"3","author":"Segman","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib29","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.mp.4000842","article-title":"Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia","volume":"6","author":"Segman","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s002130000521","article-title":"Association between the serotonin 2C receptor gene and tardive dyskinesia in chronic schizophrenia: additive contribution of 5-HT2Cser and DRD3gly alleles to susceptibility","volume":"152","author":"Segman","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.mp.4000960","article-title":"Age and the relationship of dopamine D3, serotonin 2C and serotonin 2A receptor genes to abnormal involuntary movements in chronic schizophrenia","volume":"7","author":"Segman","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s11008-005-0104-y","article-title":"Genetic variability and discriminating power of four microsatellite loci in Russian population","volume":"39","author":"Shorokhova","year":"2005","journal-title":"Mol Biol (Mosk)"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib33","unstructured":"Sokal, R. and Rohlf, F. (1994) Biometry. 3rd."},{"key":"10.1016\/j.pnpbp.2009.01.010_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/10401239709147773","article-title":"Tardive dyskinesia and ethnicity: review of the literature","volume":"9","author":"Swartz","year":"1997","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib42","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1176\/ajp.134.9.1032","article-title":"Tardive dyskinesia in young adults","volume":"134","author":"Tarsy","year":"1977","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib35","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000087338","article-title":"Variability of the 3\u2032APOB minisatellite locus in Eastern Slavonic populations","volume":"60","author":"Verbenko","year":"2005","journal-title":"Hum Hered"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib36","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpsyc.1987.01800220077011","article-title":"Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia. Their association in relation to topography of involuntary movements and criterion of their abnormality","volume":"44","author":"Waddington","year":"1987","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.tpj.6500152","article-title":"Cebus apella, a nonhuman primate highly susceptible to neuroleptic side effects, carries the GLY9 dopamine receptor D3 associated with tardive dyskinesia in humans","volume":"3","author":"Werge","year":"2003","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib38","unstructured":"Wilffert, B., Al Hadithy, A., Jangbahadoer Sing, V., Matroos, G., Hoek, H., van Os, J. et al.The role of dopamine D3, 5HT2A and 5HT2C receptor variants as pharmacogenetic determinants for tardive dyskinesia in African-Caribbean patients with chronic antipsychotic treatment. J Psychopharmacol in press."},{"key":"10.1016\/j.pnpbp.2009.01.010_bib39","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/01.jcp.0000144888.43449.54","article-title":"Ethnicity and the course of tardive dyskinesia in outpatients presenting to the motor disorders clinic at the Maryland psychiatric research center","volume":"24","author":"Wonodi","year":"2004","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pnpbp.2009.01.010_bib40","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J Clin Psychiatry"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584609000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T01:54:02Z","timestamp":1545443642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584609000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S0278584609000165"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2009.01.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}